Please login to the form below

Not currently logged in


This page shows the latest valsartan news and features for those working in and with pharma, biotech and healthcare.

Novartis acquires The Medicines Company for $9.7bn following takeover rumours

Novartis acquires The Medicines Company for $9.7bn following takeover rumours

According to Bloomberg analyst Sam Fazeli, inclisiran fits neatly into Novartis’ cardiovascular portfolio alongside  Entresto (sacubitril/valsartan), its heart failure medicine which has grown since its launch to make $1.2bn

Latest news

More from news
Approximately 7 fully matching, plus 83 partially matching documents found.

Latest Intelligence

More from intelligence
Approximately 0 fully matching, plus 2 partially matching documents found.

Featured jobs

Subscribe to our email news alerts


Add my company
Cello Health

Cello Health are expert navigators, helping healthcare clients uncover hidden insights, explore scientific options and make difficult strategic choices...

Latest intelligence

Language barriers: Obesity has become a loaded word
Spotlight interview: 15 minutes on digital in medical communications
Gemma Allen, Head of Digital Communications, OPEN Health takes 15 minutes to answer some key questions on digital in medical communications...
Generating data on long-term outcomes with gene and other advanced therapies
Gene therapy and advanced cell-based therapies offer patients hope and the potential to make them ‘chronically well’....